Invention Grant
US07931900B2 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
有权
通过抑制IL-17活性治疗多发性硬化的方法
- Patent Title: Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
- Patent Title (中): 通过抑制IL-17活性治疗多发性硬化的方法
-
Application No.: US12277030Application Date: 2008-11-24
-
Publication No.: US07931900B2Publication Date: 2011-04-26
- Inventor: Mark Ian Christie , Richard James Mead , Martyn Kim Robinson , Stephen Edward Rapecki
- Applicant: Mark Ian Christie , Richard James Mead , Martyn Kim Robinson , Stephen Edward Rapecki
- Applicant Address: BE Brussels
- Assignee: UCB Pharma S.A.
- Current Assignee: UCB Pharma S.A.
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB0327181.4 20031121; GB0417115.3 20040730
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention provides a method for the treatment and/or prophylaxis of multiple sclerosis (MS) comprising administering a therapeutically effective amount of an inhibitor of IL-17 activity.
Public/Granted literature
- US20090191200A1 Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity Public/Granted day:2009-07-30
Information query
